Larry Blankenship

Transverse Medical Inc. is a startup medical device company developing a novel, minimally invasive transcatheter mitral valve replacement (TMVR) system to treat mitral valve disease, initially in high surgical risk patients. The Transverse technology platform has the potential to address a wide range of valvular and other cardiovascular diseases. Mr. Blankenship served as a Specialty Advisor, providing expertise in the areas of Regulatory Affairs & Quality Systems, Clinical Affairs, and Design Control.

Larry Blankenship is currently a graduate student in the masters program for clinical mental health counseling at the University of Northern Colorado. Larry previously completed their undergraduate degree in Bachelor of Science from Arizona State University's College of Engineering.